Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster Randomized Trial to Determine Diagnostic and Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

NCT05029583 is registered in ClinicalTrials.gov with LMC Diabetes & Endocrinology Ltd. as lead sponsor.

NCT NCT05029583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05029583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster Randomized Trial to Determine Diagnostic and Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
August 11, 2021
Completion date
October 5, 2025
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis, type 2 diabetes